News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Myeloma Paper of the Day, July 9th, Suggested by Robert Orlowski
Jul 9, 2025, 09:12

Myeloma Paper of the Day, July 9th, Suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day:

Case report of the use of teclistamab for treatment of relapsed/refractory POEMS syndrome producing a durable biochemical and radiographic remission lasting past drug discontinuation and without any unanticipated toxicities.”

Title: Teclistamab for heavily pretreated relapsed/refractory POEMS syndrome

Authors: Alexis Talbot, Nathalie Forgeard, Tristan Vaugeois, Floriane Theves, Sabrine Dimassi, Bruno Royer, Pierre-Edouard Debureaux, Véronique Meignin, Laetitia Vercellino, David Boutboul, Bertrand Arnulf, Stéphanie Harel

You can read the Full Article in Haematologica.

Myeloma Paper of the Day, July 9th, Suggested by Robert Orlowski

You can find more posts featuring Robert Orlowski in OncoDaily.

Alexis Talbot Bertrand Arnulf Bruno Royer cancer David Boutboul Floriane Theves Laetitia Vercellino Myeloma Myeloma Paper of the Day Nathalie Forgeard OncoDaily Oncology Pierre-Edouard Debureaux POEMS syndrome Robert Orlowski Sabrine Dimassi Stephanie Harel teclistamab Tristan Vaugeois Véronique Meignin
Special Coverage
Science
Jul 9, 2025, 09:12
Myeloma Paper of the Day, July 9th, Suggested by Robert Orlowski
Career
Jul 9, 2025, 08:22
Call for Applications: Young SIOP Representative for Nutrition Network Steering Group - AIEOP
Blog
Jul 9, 2025, 01:52
Zoë Mullan: Hope to See Some Familiar Faces at 2025 Asian Conference on Implementation Science
Insight
Jul 9, 2025, 01:44
Inhibiting CDS2 Selectively Kills CDS1-deficient Cancer Cells - The Netherlands Cancer Institute
Blog
Jul 8, 2025, 20:46
Experts Driving Innovation in Radiation Oncology Through the ESTRO Focus Group
Blog
Jul 8, 2025, 20:27
Abdu Adem Yesufe: Immensely Grateful for IAEA's Support Thus Far
Blog
Jul 8, 2025, 20:24
Svetlana Nikic: Honored to Attend HBA and Almirall Event on Women’s Development
Blog
Jul 8, 2025, 20:03
Alfredo Addeo: Colloquiums of the Department of Medicine in HUG Presented a Fascinating Conference
Blog
Jul 8, 2025, 19:47
A Webinar on "Overcoming Barriers to Pediatric Cancer Care in Nepal" on July 17 - The Max Foundation
Blog
Jul 8, 2025, 19:34
Edward Cliff: A Short Taster of Our Session to the Video Journal of Hematology and Hematological Oncology
Drugs
Jul 8, 2025, 18:55
Miguel Bronchud: Who Pays for New Drugs?
Blog
Jul 8, 2025, 18:45
Women With Overweight/Obesity and a History of CVD are 31% More Likely to Develop Breast Cancer - IARC